Standardization of protocols for plant regeneration and genome editing CF1 potato cultivar to enhance scab resistance

植物再生和基因组编辑 CF1 马铃薯品种标准化方案以增强赤霉病抗性

基本信息

  • 批准号:
    531075-2018
  • 负责人:
  • 金额:
    $ 1.82万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Engage Grants Program
  • 财政年份:
    2018
  • 资助国家:
    加拿大
  • 起止时间:
    2018-01-01 至 2019-12-31
  • 项目状态:
    已结题

项目摘要

Canada produces potato in 138 thousand ha (4.6 million t, farm gate value of $1 billion per annum) and US**produces five times more. More than 200 potato cultivars are currently grown in Canada. The cultivar CF1**(registered name held confidential) is grown both in Canada and also in USA and is very susceptible to scab,**caused by Streptomyces scabies, a bacterial pathogen. The pathogen infects young tubers and causes scabby**lesions, often deforming the tubers. Current management options are not effective, often leading to severe yield**losses; in 2015, the loss only for CF1 cultivar was $800 000. Genetic resistance is the best way to manage this**disease. However, the R gene compositions of several commercial cultivars are rather poor, thus have only low**to moderate levels of resistance. Furthermore, the sexual incompatibility limits potato breeding. Based on**metabolomics and transcriptomics Kushalappa lab has identified several R genes against late blight in potato**and to fusarium head blight in wheat. These R genes biosynthesize resistance related metabolites that are**deposited to reinforce the cell walls to contain the pathogen spread; this mechanism is common to different**plants and pathogens, thus can confer multiple disease resistance. In this proposal, some of these R genes will**be sequenced in CF1, and if polymorphic, the best one will be used in genome editing. The protocol for calli**production and plant regeneration will be established. The R gene segment that is mutated in CF1 will be**replaced with the functional gene segment, based on CRISPR-Cas 9 system using geminivirus vectors. The**replaced genes will be confirmed in the regenerated plants based on amplicon sequencing. The mini-tubers of**cisgenic CF1 and the original CF1 will be produced aeroponically, young tubers will be inoculated with scab**pathogen and disease severity will be assessed to confirm enhanced resistance. After this project period, an**elaborate project will be developed to identify more polymorphic genes and to edit them in CF1 to obtain high**levels of multiple disease resistance, in collaboration with the Cavendish Farms, and submitted to**NSERC-SPG for funding.
加拿大的马铃薯产量为13.8万公顷(460万吨,每年农场价值10亿美元),美国的产量是加拿大的5倍。加拿大目前种植了200多种马铃薯品种。CF1**品种(注册名称保密)在加拿大和美国都有种植,非常容易感染疥疮**,这是由一种细菌病原体——疥疮链霉菌引起的。病原菌感染幼嫩的块茎,造成结痂性损伤,常常使块茎变形。目前的管理方案并不有效,经常导致严重的产量损失;2015年,仅CF1品种的损失为80万美元。遗传抗性是控制这种疾病的最好方法。然而,一些商品品种的R基因组成相当差,因此只有低**至中等水平的抗性。此外,性不亲和性限制了马铃薯的育种。基于代谢组学和转录组学,Kushalappa实验室已经鉴定出几个抗马铃薯晚疫病和小麦枯萎病的R基因。这些R基因生物合成与抗性相关的代谢物,这些代谢物沉积在细胞壁上,以抑制病原体的传播;这种机制在不同的植物和病原体中是共同的,因此可以赋予多重抗病能力。在本提案中,这些R基因中的一些将在CF1中进行测序,如果多态性,则将最好的一个用于基因组编辑。建立愈伤组织的产生和植株再生方案。基于双病毒载体crispr - cas9系统,将CF1中发生突变的R基因片段**替换为功能基因片段。**替换的基因将在再生植株中通过扩增子测序得到确认。将**基因CF1和原CF1的微型块茎进行气栽生产,接种痂**病原菌接种幼块茎,并评估疾病严重程度以确认抗性增强。本项目结束后,将与卡文迪什农场合作,开发一个详细的项目,以确定更多的多态性基因,并在CF1中对其进行编辑,以获得高水平的多种疾病抗性,并提交给NSERC-SPG申请资助。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kushalappa, Ajjamada其他文献

Kushalappa, Ajjamada的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kushalappa, Ajjamada', 18)}}的其他基金

Resistance in plants against biotic stress through forward and reverse genetics
通过正向和反向遗传学使植物抵抗生物胁迫
  • 批准号:
    RGPIN-2016-05063
  • 财政年份:
    2021
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Discovery Grants Program - Individual
Resistance in plants against biotic stress through forward and reverse genetics
通过正向和反向遗传学使植物抵抗生物胁迫
  • 批准号:
    RGPIN-2016-05063
  • 财政年份:
    2020
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Discovery Grants Program - Individual
Resistance in plants against biotic stress through forward and reverse genetics
通过正向和反向遗传学使植物抵抗生物胁迫
  • 批准号:
    RGPIN-2016-05063
  • 财政年份:
    2019
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Discovery Grants Program - Individual
Resistance in plants against biotic stress through forward and reverse genetics
通过正向和反向遗传学使植物抵抗生物胁迫
  • 批准号:
    RGPIN-2016-05063
  • 财政年份:
    2018
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Discovery Grants Program - Individual
Resistance in plants against biotic stress through forward and reverse genetics
通过正向和反向遗传学使植物抵抗生物胁迫
  • 批准号:
    RGPIN-2016-05063
  • 财政年份:
    2017
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Discovery Grants Program - Individual
Resistance in plants against biotic stress through forward and reverse genetics
通过正向和反向遗传学使植物抵抗生物胁迫
  • 批准号:
    RGPIN-2016-05063
  • 财政年份:
    2016
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Discovery Grants Program - Individual
Mechanisms of resistance in plants against biotic stress through metabolomics proeomics and lignomics
通过代谢组学、蛋白质组学和木质组学研究植物抵抗生物胁迫的机制
  • 批准号:
    3739-2011
  • 财政年份:
    2015
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Discovery Grants Program - Individual
Mechanisms of resistance in plants against biotic stress through metabolomics proeomics and lignomics
通过代谢组学、蛋白质组学和木质组学研究植物抵抗生物胁迫的机制
  • 批准号:
    3739-2011
  • 财政年份:
    2014
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Discovery Grants Program - Individual
Mechanisms of resistance in plants against biotic stress through metabolomics proeomics and lignomics
通过代谢组学、蛋白质组学和木质组学研究植物抵抗生物胁迫的机制
  • 批准号:
    3739-2011
  • 财政年份:
    2013
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Discovery Grants Program - Individual
Mechanisms of resistance in plants against biotic stress through metabolomics proeomics and lignomics
通过代谢组学、蛋白质组学和木质组学研究植物抵抗生物胁迫的机制
  • 批准号:
    3739-2011
  • 财政年份:
    2012
  • 资助金额:
    $ 1.82万
  • 项目类别:
    Discovery Grants Program - Individual

相似海外基金

Light-propelled dental adhesives with enhanced bonding capability
具有增强粘合能力的光驱动牙科粘合剂
  • 批准号:
    10741660
  • 财政年份:
    2023
  • 资助金额:
    $ 1.82万
  • 项目类别:
Modernization of 3-dimensional printing capabilities at the Aquatic Germplasm and Genetic Resource Center
水产种质和遗传资源中心 3 维打印能力的现代化
  • 批准号:
    10736961
  • 财政年份:
    2023
  • 资助金额:
    $ 1.82万
  • 项目类别:
Innovative Sorbents for Stabilizing Per- and Polyfluoroalky Substances (PFAS) in Soil Contaminated by Aqueous Film-forming Foam (AFFF)
用于稳定受水成膜泡沫 (AFFF) 污染的土壤中的全氟和多氟烷基物质 (PFAS) 的创新吸附剂
  • 批准号:
    10697401
  • 财政年份:
    2023
  • 资助金额:
    $ 1.82万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10712291
  • 财政年份:
    2023
  • 资助金额:
    $ 1.82万
  • 项目类别:
Novel Antibiofilm Treatments for Pseudomonas aeruginosa Infection
治疗铜绿假单胞菌感染的新型抗菌膜疗法
  • 批准号:
    10648172
  • 财政年份:
    2023
  • 资助金额:
    $ 1.82万
  • 项目类别:
Engineered Pan-Specific Reagents for N-Glycan Detection and Enrichment
用于 N-聚糖检测和富集的工程泛特异性试剂
  • 批准号:
    10761111
  • 财政年份:
    2023
  • 资助金额:
    $ 1.82万
  • 项目类别:
Effects of digestion on composition and bioavailability of compounds from Ashwagandha: an in vitro study
消化对 Ashwagandha 化合物的组成和生物利用度的影响:一项体外研究
  • 批准号:
    10711567
  • 财政年份:
    2023
  • 资助金额:
    $ 1.82万
  • 项目类别:
Leaf-Derived Vascular Scaffolds (LeaVS): A multifunctional platform for skin regeneration
叶源血管支架(LeaVS):皮肤再生的多功能平台
  • 批准号:
    10579706
  • 财政年份:
    2023
  • 资助金额:
    $ 1.82万
  • 项目类别:
In vitro assessment of kratom pharmacokinetic CYP interactions with HIV ART drug metabolism
卡痛叶药代动力学 CYP 与 HIV ART 药物代谢相互作用的体外评估
  • 批准号:
    10746628
  • 财政年份:
    2023
  • 资助金额:
    $ 1.82万
  • 项目类别:
Placental Organoids for Modeling and Treating Preeclampsia
用于建模和治疗先兆子痫的胎盘类器官
  • 批准号:
    10464766
  • 财政年份:
    2022
  • 资助金额:
    $ 1.82万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了